Information:
Error:
ID
28336
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 11/30/17 11/30/17 -
- 1/4/18 1/4/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
January 4, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening Registration GOAL Trial B-cell Lymphoma NCT02499003
Screening Registration GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Screening Registration GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
compliance inclusion criteria
Item
Subject complies with all inclusion criteria?
boolean
C1321605 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
compliance exclusion criteria
Item
Subject complies with all exclusion criteria?
boolean
C1321605 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])
Inclusion in study
Item
Include subject into study?
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
Patient number
Item
Patient No.
integer
C1830427 (UMLS CUI [1])
No comments